Stay Updated with the Latest Securitas AB (publ) S7MB.BE News in Real Time
Find S7MB.BE news now at Meyka AI. Stay informed with the latest Securitas AB (publ) stocks updates, including price news, market analysis, and expert insights.
Swedencare (STO: SECARE) Shares Plunge 17% After Q2 Revenue Misses Analyst Estimates
Swedencare shares plunged 17% Wednesday after second-quarter results missed Wall Street expectations. The pet health company reported net sales of SEK 670 million for Q2 2026. That figure grew just 4% year-over-year but missed consensus estimates by 4%. Operational EBITDA reached SEK 129 million, also up 4%, yet fell 5% short of forecasts. North America…
Securitas AB falls 3% as 2030 EPS growth target raises execution and deal concerns
Securitas AB shares slid roughly 3% on June 16, 2026, after the Swedish security giant unveiled its long-awaited 2030 strategy. Securitas presented updated financial targets on June 15, 2026, headlined by a new goal of 10% average annual earnings-per-share growth over a business cycle. The announcement was paired with an Investor Day held in London…
LBGUF Earnings Beat: L E Lundbergföretagen Q2 2026 Results
LBGUF reported Q2 2026 earnings on May 21, 2026 with $2.02 EPS and $868.45M revenue. Meyka AI rates the stock B+.
Xvivo Perfusion AB (XVIPY) Holds $6.54 as Organ Transplant Tech Faces Valuation Pressure
XVIPY stock trades flat at $6.54 USD on PNK. Medical device company faces high valuation multiples despite strong 6-month gains of 40%.
BRCTF Earnings Beat: BioArctic AB (publ) Crushes Q2 2026 Estimates
BioArctic AB (BRCTF) beat Q2 2026 earnings on May 20 with EPS of $0.2514 vs. -$0.0316 estimate and $46.04M revenue vs. $20.26M expected.
NDRBF Earnings Beat: NIBE Industrier Q2 2026 Results
NDRBF beats EPS and revenue estimates in Q2 2026 earnings. NIBE Industrier reports $0.0263 EPS vs $0.0257 estimate, $1.02B revenue.
Beyond Frames Entertainment Stock Slips 1.9% Ahead of Earnings
8WP.F stock drops 1.9% to €0.207 on XETRA ahead of May 21 earnings announcement. Gaming firm faces profitability challenges.
Xvivo Perfusion AB (XVIPY) Holds $6.54 as Organ Transplant Tech Faces Valuation Pressure
XVIPY stock trades flat at $6.54 USD. Medical device maker faces elevated valuation metrics and mixed analyst outlook in healthcare sector.
BioArctic AB (BRCTF) Earnings Preview: EPS Seen at -$0.0316 on Q2 2026
BRCTF earnings preview: BioArctic AB (publ) reports May 20, 2026. EPS estimate -$0.0316, revenue $20.26M. Analyst expectations and key metrics.